Genitourinary Malignancies

Postresection intravesical instillation of gemcitabine decreases non-muscle-invasive urothelial cancer recurrence

1. In this randomized controlled trial, time to recurrence was lower in patient with non-muscle-invasive urothelial cancer when treated with intravesical gemcitabine as compared to saline controls. 2. There was no difference in all-cause mortality between the two treatment groups. Evidence Rating: 1 (Excellent) Study Rundown: Non-muscle-invasive urothelial cancer is the most common form of []

Cabozantinib Active in Hepatocellular Carcinoma

Cabozantinib Active in Hepatocellular Carcinoma

By

Treatment with cabozantinib was active and associated with manageable toxicities in patients with hepatocellular carcinoma.

Nivolumab Monotherapy Active in Recurrent Metastatic Urothelial Carcinoma

By

Single-agent nivolumab induced durable clinical responses with a manageable safety profile in previously treated patients with locally advanced or metastatic urothelial carcinoma.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs